Somanetics Corporation (Nasdaq: SMTS) announced a new 510(k) clearance from the FDA to expand the labeling for its INVOS(R) Cerebral/Somatic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE